WallStreetZenWallStreetZen

NASDAQ: DRRX
Durect Corp Stock

$2.66-0.05 (-1.85%)
Updated Sep 22, 2023
DRRX Price
$2.66
Fair Value Price
$4.30
Market Cap
$73.42M
52 Week Low
$2.64
52 Week High
$9.50
P/E
-1.76x
P/B
13.35x
P/S
6.25x
PEG
N/A
Dividend Yield
N/A
Revenue
$19.43M
Earnings
-$36.11M
Gross Margin
91.7%
Operating Margin
-171.7%
Profit Margin
-185.9%
Debt to Equity
7.85
Operating Cash Flow
-$29M
Beta
1.15
Next Earnings
Oct 31, 2023
Ex-Dividend
N/A
Next Dividend
N/A

DRRX Overview

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DRRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DRRX ($2.66) is undervalued by 38.16% relative to our estimate of its Fair Value price of $4.30 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
DRRX ($2.66) is significantly undervalued by 38.16% relative to our estimate of its Fair Value price of $4.30 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
DRRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more DRRX due diligence checks available for Premium users.

Be the first to know about important DRRX news, forecast changes, insider trades & much more!

DRRX News

Valuation

DRRX fair value

Fair Value of DRRX stock based on Discounted Cash Flow (DCF)
Price
$2.66
Fair Value
$4.30
Undervalued by
38.16%
DRRX ($2.66) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
DRRX ($2.66) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
DRRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

DRRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.76x
Industry
26.36x
Market
14.52x

DRRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
13.35x
Industry
2x
DRRX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DRRX's financial health

Profit margin

Revenue
$2.1M
Net Income
-$11.2M
Profit Margin
-537.3%
DRRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DRRX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$48.7M
Liabilities
$43.2M
Debt to equity
7.85
DRRX's short-term liabilities ($41.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DRRX's short-term assets ($40.29M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DRRX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
DRRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.3M
Investing
$1.8M
Financing
-$34.0k
DRRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

DRRX vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
DRRX$73.42M-1.85%-1.76x13.35x
INCR$74.06M-0.91%N/A0.55x
ZYNE$72.28M0.00%-1.70x2.49x
BGXX$60.53M-12.47%-3.74x4.54x
CRDL$58.36M-3.19%-2.56x1.99x

Durect Stock FAQ

What is Durect's quote symbol?

(NASDAQ: DRRX) Durect trades on the NASDAQ under the ticker symbol DRRX. Durect stock quotes can also be displayed as NASDAQ: DRRX.

If you're new to stock investing, here's how to buy Durect stock.

What is the 52 week high and low for Durect (NASDAQ: DRRX)?

(NASDAQ: DRRX) Durect's 52-week high was $9.50, and its 52-week low was $2.64. It is currently -72% from its 52-week high and 0.76% from its 52-week low.

How much is Durect stock worth today?

(NASDAQ: DRRX) Durect currently has 27,600,079 outstanding shares. With Durect stock trading at $2.66 per share, the total value of Durect stock (market capitalization) is $73.42M.

Durect stock was originally listed at a price of $144.10 in Sep 28, 2000. If you had invested in Durect stock at $144.10, your return over the last 22 years would have been -98.15%, for an annualized return of -16.6% (not including any dividends or dividend reinvestments).

How much is Durect's stock price per share?

(NASDAQ: DRRX) Durect stock price per share is $2.66 today (as of Sep 22, 2023).

What is Durect's Market Cap?

(NASDAQ: DRRX) Durect's market cap is $73.42M, as of Sep 23, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Durect's market cap is calculated by multiplying DRRX's current stock price of $2.66 by DRRX's total outstanding shares of 27,600,079.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.